Hyasynth Bio: Organigram Invests Additional $2.5 Mln In Hyasynth Biologicals

Organigram Holdings Inc., the parent company of Canada-based cannabis producer Organigram Inc., said it has invested an additional $2.5 million in Hyasynth Biologicals Inc., a Canada-based private biotechnology company that focuses on the manufacture of cannabinoids using biosynthesis.